Coherus Biosciences (CHRS)
NASDAQ:CHRS
Holding CHRS?
Track your performance easily

Coherus Biosciences (CHRS) Financial Statements

1,341 Followers

Coherus Biosciences Financial Overview

Coherus Biosciences's market cap is currently ―. The company's EPS TTM is $-0.413; its P/E ratio is -2.54; Coherus Biosciences is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 64.98M$ 77.06M$ 91.52M$ 74.57M$ 58.72M
Gross Profit$ 36.61M$ 42.48M$ 6.96M$ 41.87M$ 33.87M
EBIT$ -7.59M$ 113.99M$ -69.03M$ -29.75M$ -32.93M
EBITDA$ -6.40M$ 115.50M$ -67.97M$ -28.87M$ -32.37M
Net Income Common Stockholders$ -12.89M$ 102.88M$ -79.65M$ -39.64M$ -42.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 159.24M$ 259.77M$ 117.75M$ 131.08M$ 144.71M
Total Assets$ 674.86M$ 763.55M$ 629.60M$ 583.78M$ 469.61M
Total Debt$ 227.56M$ 402.22M$ 226.89M$ 226.56M$ 226.23M
Net Debt$ 68.31M$ 142.44M$ 109.14M$ 95.48M$ 81.52M
Total Liabilities$ 758.96M$ 845.42M$ 823.03M$ 717.38M$ 644.36M
Stockholders Equity$ -84.11M$ -81.84M$ -193.43M$ -133.60M$ -174.76M
Cash Flow-
Free Cash Flow$ 59.73M$ 141.06M$ -12.97M$ -54.15M$ -38.58M
Operating Cash Flow$ 59.73M$ -46.77M$ -12.94M$ -54.30M$ -38.91M
Investing Cash Flow$ 27.66M$ 202.76M$ 35.20M$ 50.55M$ 41.37M
Financing Cash Flow$ -187.93M$ 887.00K$ 366.00K$ 11.11M$ 54.33M
Currency in USD

Coherus Biosciences Earnings and Revenue History

Coherus Biosciences Debt to Assets

Coherus Biosciences Cash Flow

Coherus Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis